Search - tctmd.com

Displaying 141 - 160 of 386

Sort: Relevancy | Date

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

Presentation TCT 2020

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

Presenter: Matthew Mercieca Balbi

October 14, 2020

Presentation TCT 2020

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

Presenter: Tomoki Ochiai

October 14, 2020

Presentation TCT 2020

TCT 017: Ambient Temperature and Infarct Size, Microvascular Obstruction, Left Ventricular Function and Clinical Outcomes After STEMI

Presenter: Matheus Santos

October 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

Shelley Wood

July 24, 2020

News Conference News EuroPCR 2020

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Yael L. Maxwell

July 03, 2020

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

Lancet COVID-19 Hydroxychloroquine Study Faces ‘Data Integrity’ Questions

News Daily News

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Michael O'Riordan

June 01, 2020

News Daily News

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

Michael O'Riordan

May 27, 2020

News Daily News

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Yael L. Maxwell

April 22, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News ACC 2020

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

Shelley Wood

March 29, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

News Daily News

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

Yael L. Maxwell

February 14, 2020

News Daily News

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

Yael L. Maxwell

January 16, 2020

Presentation TCT Abstracts Posters 2019

MOCA I Study – Microvascular Obstruction Treatment Efficacy Measured by Using Dynamic Microvascular Resistance (dMVR)

Presenter: Valgimigli M.

October 17, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

Advertisement

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

TCT 464: Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement

TCT 017: Ambient Temperature and Infarct Size, Microvascular Obstruction, Left Ventricular Function and Clinical Outcomes After STEMI

Which TAVR Device Is Best? Review Tackles Optimal Selection

Which Modality and When? New Guidance for Cardiac Imaging in COVID-19

ViV TAVR: New Durability and BASILICA Data Stress Need to Plan Ahead

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Newer TAVR Devices Reassure in Failed Surgical Valves

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

TAVR Bests Surgical Redo for Failed Bioprostheses: Early Data

Good Results With Next-Gen, Self-Expanding TAVR in Bicuspid Valves

No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Preemptive Stents Feasible for TAVR Patients at High Risk for Coronary Occlusion

ViV TAVR Bests Redo Surgery for Failed Valves: Retrospective Study

MOCA I Study – Microvascular Obstruction Treatment Efficacy Measured by Using Dynamic Microvascular Resistance (dMVR)

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content